posted on 2017-11-01, 14:45authored bySamantha Johnson, Ghazala Waheed, Bradley N. Manktelow, David J. Field, Neil Marlow, Elizabeth S. Draper, Elaine M. Boyle
Objectives: To explore patterns of comorbidity in cognitive and behavioural outcomes at two
years corrected age among children born late and moderately preterm (LMPT) and to identify
predictors of different patterns of comorbidity in this population.
Study design: Geographical prospective population-based cohort study of 1139 LMPT (32+0
to 36+6 weeks’ gestation) and 1255 term-born (37+0 to 42+6 weeks’ gestation) babies. Parent
questionnaires were used to identify impaired cognitive and language development,
behaviour problems, delayed social-emotional competence, autistic features and clinicallysignificant
eating difficulties at 24 months corrected age for 638 (57%) LMPT and 765 (62%)
term-born children.
Results: Latent Class Analysis revealed two classes of outcomes among the term group:
optimal outcome (Class I: 84%) and non-optimal outcome (Class 2: 16%). In contrast, three
classes were identified in the LMPT group: optimal outcome (Class 1: 67%), non-optimal
outcome (Class 2: 26%), and an additional preterm phenotype (Class 3: 7%). Non-white
ethnicity, socio-economic risk and not receiving breast milk at hospital discharge were risk
factors for non-optimal outcome in both groups. Male sex, higher gestational age and
preeclampsia were only associated with the preterm phenotype.
Conclusions: Only a small proportion of LMPT born children have cognitive and
behavioural problems that are consistent with the very preterm phenotype and which are
likely to have arisen through a preterm pathway. A larger proportion have a profile of
problems that correspond with those observed in children born at term. This study advances
understanding of the long term risks attached to birth at late and moderately preterm
gestations.
Funding
This article presents independent research funded by the National Institute
for Health Research (NIHR) under its Programme Grants for Applied Research (PGfAR)
Programme (Grant Reference Number RP-PG-0407-10029). The views expressed are those
of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health.
Neil Marlow receives a proportion of funding from the Department of Health’s NIHR
Biomedical Research Centres funding scheme at UCLH/UCL.
History
Citation
Journal of Pediatrics, 2017
Author affiliation
/Organisation/COLLEGE OF LIFE SCIENCES/School of Medicine/Department of Health Sciences
The file associated with this record is under embargo until 12 months after publication, in accordance with the publisher's self-archiving policy. The full text may be available through the publisher links provided above.